Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
Background. This study aimed to evaluate the risk factors of HCC development in patients with hepatitis B virus (HBV)-related DC and who underwent long-term antiviral therapy. Methods. Data from 308 patients with HBV-related DC and long-term antiviral therapy were collected and retrospectively revie...
Main Authors: | Dong-Mei Zhu, Jing Xie, Chun-Yan Ye, Mei-Yun Qian, Yuan Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/8871024 |
Similar Items
-
Effect of antiviral therapy on long-term prognosis of patients with decompensated hepatitis B cirrhosis
by: YANG Hanze
Published: (2016-06-01) -
Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
by: Joon Yeul Nam, et al.
Published: (2020-12-01) -
Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
by: JianPing Wu, et al.
Published: (2019-01-01) -
Serum potassium levels and prognosis in HBV-associated decompensated cirrhosis
by: Cai, M., et al.
Published: (2021) -
Diagnosis and treatment of hepatocellular carcinoma after 8-year treatment of decompensated HBV-related liver cirrhosis: a report of one case
by: HAO Juan
Published: (2015-06-01)